{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:46:48Z","timestamp":1787028408606,"version":"build-2736575974"},"reference-count":77,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tokyo Metropolitan Government","award":["H260301002"],"award-info":[{"award-number":["H260301002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sarcopenia, the degenerative and systemic loss of skeletal muscle mass, indicates patient frailty and impaired physical function. Sarcopenia can be caused by multiple factors, including advanced age, lack of exercise, poor nutritional status, inflammatory diseases, endocrine diseases, and malignancies. In patients with cancer cachexia, anorexia, poor nutrition and systemic inflammation make the metabolic state more catabolic, resulting in sarcopenia. Thus, sarcopenia is considered as one of manifestations of cancer cachexia. Recently, growing evidence has indicated the importance of sarcopenia in the management of patients with various cancers. Sarcopenia is associated with not only higher rates of treatment-related complications but also worse prognosis in cancer-bearing patients. In this article, we summarized metabolic backgrounds of cancer cachexia and sarcopenia and definitions of sarcopenia based on computed tomography (CT) images. We conducted a systematic literature review regarding the significance of sarcopenia as a prognostic biomarker of bladder cancer. We also reviewed recent studies focusing on the prognostic role of changes in skeletal muscle mass during the course of treatment in bladder cancer patients. Lastly, we discussed the impact of nutritional support, medication, and exercise on sarcopenia in cancer-bearing patients.<\/jats:p>","DOI":"10.3390\/ijms19102999","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T08:23:50Z","timestamp":1538468630000},"page":"2999","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer"],"prefix":"10.3390","volume":"19","author":[{"given":"Hiroshi","family":"Fukushima","sequence":"first","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Takemura","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7888-0085","authenticated-orcid":false,"given":"Fumitaka","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer","volume":"71","author":"Witjes","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-5347(05)66440-3","article-title":"Cystectomy for bladder cancer: A contemporary series","volume":"165","author":"Dalbagni","year":"2001","journal-title":"J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/JCO.2011.38.6979","article-title":"Randomized phase III study comparing paclitaxel\/cisplatin\/gemcitabine and gemcitabine\/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987","volume":"30","author":"Bellmunt","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14737140.2018.1421461","article-title":"Pembrolizumab for the treatment of bladder cancer","volume":"18","author":"Sundahl","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Baeyens","year":"2010","journal-title":"Age Ageing"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11005\/jbm.2013.20.1.1","article-title":"Sarcopenia: Definition, epidemiology, and pathophysiology","volume":"20","author":"Kim","year":"2013","journal-title":"J. Bone Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11357-011-9327-0","article-title":"Genes and the ageing muscle: A review on genetic association studies","volume":"35","author":"Garatachea","year":"2013","journal-title":"Age"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jcsm.12073","article-title":"Sarcopenia and mortality among a population-based sample of community-dwelling older adults","volume":"7","author":"Brown","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ageing\/afs194","article-title":"Sarcopenia and mortality risk in frail older persons aged 80 years and older: Results from ilSIRENTE study","volume":"42","author":"Landi","year":"2013","journal-title":"Age Ageing"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1017\/BJN20061943","article-title":"Sarcopenia is predictive of nosocomial infection in care of the elderly","volume":"96","author":"Cosqueric","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3961\/jpmph.15.055","article-title":"Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength","volume":"49","author":"Lee","year":"2016","journal-title":"J. Prev. Med. Public Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00198-014-2745-y","article-title":"Early-stage chronic kidney disease, insulin resistance, and osteoporosis as risk factors of sarcopenia in aged population: The fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008\u20132009","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3346\/jkms.2015.30.3.264","article-title":"Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score","volume":"30","author":"Kim","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br. J. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/dote.12381","article-title":"Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma","volume":"29","author":"Harada","year":"2016","journal-title":"Dis. Esophagus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jcsm.12115","article-title":"Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"7","author":"Go","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a prognostic factor among patients with stage III melanoma","volume":"18","author":"Sabel","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.juro.2015.08.072","article-title":"Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer","volume":"195","author":"Psutka","year":"2016","journal-title":"J. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.juro.2015.08.071","article-title":"Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma","volume":"195","author":"Fukushima","year":"2016","journal-title":"J. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4161\/15384047.2014.987075","article-title":"Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice","volume":"16","author":"Kliewer","year":"2015","journal-title":"Cancer Boil. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nm.4093","article-title":"Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia","volume":"22","author":"Fukawa","year":"2016","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-007-0177-2","article-title":"Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia","volume":"85","author":"Schmitt","year":"2007","journal-title":"J. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"C986","DOI":"10.1152\/ajpcell.00041.2008","article-title":"TNF induction of atrogin-1\/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1\/3 signaling","volume":"295","author":"Moylan","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13539-012-0071-9","article-title":"Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency","volume":"3","author":"Julienne","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","article-title":"Intramyocellular lipid droplets increase with progression of cachexia in cancer patients","volume":"2","author":"Stephens","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/14737140.2017.1301209","article-title":"Impact of sarcopenia in the management of urological cancer patients","volume":"17","author":"Fukushima","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.nut.2016.04.003","article-title":"Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults","volume":"32","author":"Hamaguchi","year":"2016","journal-title":"Nutrition"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/apha.12224","article-title":"Measurement of skeletal muscle radiation attenuation and basis of its biological variation","volume":"210","author":"Aubrey","year":"2014","journal-title":"Acta Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1079\/PNS2004351","article-title":"The molecular mechanism linking muscle fat accumulation to insulin resistance","volume":"63","author":"Hulver","year":"2004","journal-title":"Proc. Nutr. Soc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int. J. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.eururo.2010.02.024","article-title":"Prevention and management of complications following radical cystectomy for bladder cancer","volume":"57","author":"Lawrentschuk","year":"2010","journal-title":"Eur. Urol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7819-12-14","article-title":"Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer","volume":"12","author":"Wan","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.juro.2013.12.047","article-title":"Sarcopenia as a predictor of complications and survival following radical cystectomy","volume":"191","author":"Smith","year":"2014","journal-title":"J. Urol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.28798","article-title":"Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality","volume":"120","author":"Psutka","year":"2014","journal-title":"Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1245\/s10434-016-5606-4","article-title":"Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy","volume":"23","author":"Hirasawa","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Miyake, M., Morizawa, Y., Hori, S., Marugami, N., Shimada, K., Gotoh, D., Tatsumi, Y., Nakai, Y., Inoue, T., and Anai, S. (2017). Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3325-2"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Saitoh-Maeda, Y., Kawahara, T., Miyoshi, Y., Tsutsumi, S., Takamoto, D., Shimokihara, K., Hayashi, Y., Mochizuki, T., Ohtaka, M., and Nakamura, M. (2017). A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy. BMC Urol., 17.","DOI":"10.1186\/s12894-017-0279-2"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jcsm.12279","article-title":"Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer","volume":"9","author":"Mayr","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Fukushima, H., Yokoyama, M., Nakanishi, Y., Tobisu, K., and Koga, F. (2015). Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0115895"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clgc.2015.07.015","article-title":"Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma","volume":"14","author":"Taguchi","year":"2016","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7981549","DOI":"10.1155\/2017\/7981549","article-title":"A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy","volume":"2017","author":"Kasahara","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10147-017-1207-x","article-title":"Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy","volume":"23","author":"Abe","year":"2018","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/BLC-160080","article-title":"Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer","volume":"3","author":"Zargar","year":"2017","journal-title":"Bladder Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"156.e9","DOI":"10.1016\/j.urolonc.2017.09.016","article-title":"Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy","volume":"36","author":"Fukushima","year":"2018","journal-title":"Urol. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kays, J.K., Shahda, S., Stanley, M., Bell, T.M., O\u2019Neill, B.H., Kohli, M.D., Couch, M.E., Koniaris, L.G., and Zimmers, T.A. (2018). Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer. J. Cachexia Sarcopenia Muscle.","DOI":"10.1002\/jcsm.12307"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3803\/EnM.2015.30.3.235","article-title":"Connecting Myokines and Metabolism","volume":"30","author":"Ahima","year":"2015","journal-title":"Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","article-title":"Cancer cachexia: Impact, mechanisms and emerging treatments","volume":"4","author":"Vaughan","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_60","first-page":"3604","article-title":"Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid","volume":"61","author":"Whitehouse","year":"2001","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.freeradbiomed.2016.07.031","article-title":"4-Hydroxyhexenal and 4-hydroxynonenal are mediators of the anti-cachectic effect of n-3 and n-6 polyunsaturated fatty acids on human lung cancer cells","volume":"99","author":"Muzio","year":"2016","journal-title":"Free. Radic. Boil. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Newell, M., Baker, K., Postovit, L.M., and Field, C.J. (2017). A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081784"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20100597","article-title":"Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women","volume":"121","author":"Smith","year":"2011","journal-title":"Clin. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gutjnl-2013-306445","article-title":"Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid","volume":"63","author":"Cockbain","year":"2014","journal-title":"Gut"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Oliveira, A.G., and Gomes-Marcondes, M.C. (2016). Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2424-9"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Beluzi, M., Peres, S.B., Henriques, F.S., Sertie, R.A., Franco, F.O., Santos, K.B., Knobl, P., Andreotti, S., Shida, C.S., and Neves, R.X. (2015). Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: Possible anti-cachectic effect. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122660"},{"key":"ref_70","first-page":"156","article-title":"Sarcopenia and muscle function during menopause and hormone-replacement therapy","volume":"4","author":"Dionne","year":"2000","journal-title":"J. Nutr. Health Aging"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","article-title":"Effect of physical exercise on muscle mass and strength in cancer patients during treatment\u2014A systematic review","volume":"88","author":"Stene","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1249\/MSS.0b013e31829a3b63","article-title":"Impact of resistance training in cancer survivors: A meta-analysis","volume":"45","author":"Strasser","year":"2013","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","article-title":"Cancer cachexia prevention via physical exercise: Molecular mechanisms","volume":"4","author":"Gould","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Mijwel, S., Cardinale, D.A., Norrbom, J., Chapman, M., Ivarsson, N., Wengstrom, Y., Sundberg, C.J., and Rundqvist, H. (2018). Exercise training during chemotherapy preserves skeletal muscle fiber area, capillarization, and mitochondrial content in patients with breast cancer. FASEB J.","DOI":"10.1096\/fj.201700968R"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","article-title":"Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution","volume":"23","author":"Pedersen","year":"2016","journal-title":"Cell Metab."},{"key":"ref_76","first-page":"908","article-title":"Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression","volume":"29","author":"Koelwyn","year":"2015","journal-title":"Oncology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-16-3125","article-title":"Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development","volume":"77","author":"Dethlefsen","year":"2017","journal-title":"Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/2999\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:23:29Z","timestamp":1760196209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/2999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":77,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["ijms19102999"],"URL":"https:\/\/doi.org\/10.3390\/ijms19102999","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}